Dr Reddy’s Laboratories announces launch of Hervycta (trastuzumab biosimilar) in India
Hervycta is indicated for the treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark announces study supporting biosimilarity criteria for GBR 310 compared to the reference…
Glenmark is seeking use of GBR 310 for the same indications as the reference biologic for the treatment of allergic asthma and…
Opportunity for biotech firms to pursue drug candidates targeting metabolic disorders: GlobalData
The report also found that big pharma companies lag behind small bio-techs in R&D efforts
Kilitch Drugs announces appointment of new members to the board
VS Rajan and Prof VK Murti have been appointed as the new members
Sun Pharma announces launch of Generic Glumetza Tablets in US
The tablets are used to improve glycemic control in adults with type 2 diabetes
LifCare raises $11M Series B from SAIF Partners, Nexus Venture Partners and IL&FS
Expanding from medicine delivery, LifCare will also be providing end to end services that chronic patients need to manage their…
GlaxoSmithKline Pharmaceuticals delivers Q1 Revenues of 736 crores, growing at 21%
The significant revenue and profit growth of this quarter is due to base effect of trade channel de-stocking ahead of the…
BR Shetty-led BRS Ventures enters Afghanistan; establishes pharma manufacturing unit
BRS Ventures to also handle Operations & Management of Sheikh Zayed Hospital (SZ Hospital) and Wazir Akbar Khan Hospital (WAK…
Angle Training Forum hosts first ever ‘Kumbh Mela’ of pharma trainers
The Training Conclave organsied by “Angle Training Forum” had representation from almost two thirds of the pharma industry, by…
Alkem Labs gets EIR from USFDA for its Daman facility
Shares of Alkem Laboratories today closed at INR 2,026.35 per scrip on BSE